| Code | 2198A | ||||||||||
| MA number | 87/0365/12-S | ||||||||||
| Product Form: | sol inj 1x3 ml/3 mg (striek.inj.napl.skl.+1x inj.ihla) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | STADA Arzneimittel AG, Germany | ||||||||||
| Therapeutic Class: | 87 - VARIA I | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | pre-filled syringe | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 31.07.2012 |
| Pediatric posology: | Yes |
| PIL: |
PIL_Ibandronic acid STADA_01.2023.pdf
|
| SPC: |
SPC_Ibandronic acid STADA_01.2023.pdf
|
| Safety feature | Yes |
| Data update: | 10.10.2018 |
